irinotecan

基本解释

• 依立替康

同根派生

英汉例句

• Irinotecan is the specific inhibitor of topoismerase I.
  伊立替康是拓扑异构酶I的特异性抑制剂。
• The recommended phase II dose of irinotecan was 180 mg/m2.
  结果进入研究的病例平均进行了6个疗程的化疗。
• Objective To evaluate the clinical efficacy and adverse effects of irinotecan(CPT-11) combined with 5-Fu/FA in treatment of advanced colorectal cancer.
  目的评价CPT-11联合5-Fu/FA方案治疗晚期结直肠癌的临床疗效及毒副反应。
• Objective The aim of this study is to evaluate the efficacy and safety of the irinotecan and cisplatin combination in relapsed advanced SCLC.
  目的观察伊立替康联合顺铂方案治疗复治性晚期小细胞肺癌的疗效和安全性。
• In the 1990s, two additional agents, irinotecan and oxaliplatin, were found to have activity against advanced colorectal cancer.
  20世纪90年代出现的另外两个药物伊立替康和奥沙利铂被发现对晚期结直肠癌有效。